Formulation and evaluation of morin-loaded solid lipid nanoparticles

Biological and Pharmaceutical Bulletin

Volumn 39, Issue 9, 2016, Pages 1514-1522

  Ikeuchi Takahashi, Yuri ^a   Ishihara, Chizuko ^b   Onishi, Hiraku ^a  

^a HOSHI UNIVERSITY   (Japan)

^b Nippon Synthetic Chemical Industry Co Ltd   (Japan)

Author keywords

Bioavailability; Hard fat; Morin; Polyvinyl alcohol; Solid lipid nanoparticle

Indexed keywords

ETHYL CELLULOSE; MORIN; POLYSORBATE; POLYVINYL ALCOHOL; SOLID LIPID NANOPARTICLE; CELLULOSE; DRUG CARRIER; FAT; FLAVONOID; NANOPARTICLE;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; DRUG FORMULATION; DRUG RELEASE; DRUG SCREENING; MAXIMUM PLASMA CONCENTRATION; MOUSE; NONHUMAN; PARTICLE SIZE; POLYMERIZATION; REPRODUCIBILITY; SAPONIFICATION; TABLET HARDNESS; ZETA POTENTIAL; ANALOGS AND DERIVATIVES; ANIMAL; BLOOD; CHEMISTRY; MALE; MEDICINAL CHEMISTRY;

ANIMALS; CELLULOSE; CHEMISTRY, PHARMACEUTICAL; DRUG CARRIERS; DRUG LIBERATION; FATS; FLAVONOIDS; MALE; MICE; NANOPARTICLES; PARTICLE SIZE; POLYSORBATES; POLYVINYL ALCOHOL;

EID: 84984697504     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.b16-00300     Document Type: Article

References (35)

1. Lister C, Niki E, editor. Antioxidants: A health revolution. Fragrance Journal Ltd., Tokyo, pp. 39-41 (2006).
2. Ferguson LR. Role of plant polyphenols in genomic stability. Mutat. Res., 18, 89-111 (2001).
3. Hsiu SL, Tsao CW, Tsai YC, Ho HJ, Chao PD. Determinations of morin, quercetin and their conjugate metabolites in serum. Biol. Pharm. Bull., 24, 967-969 (2001).
4. Beker BY, Bakir T, Sönmezoǧlu I, Imer F, Apak R. Antioxidant protective effect of flavonoids on linoleic acid peroxidation induced by copper(II)/ascorbic acid system. Chem. Phys. Lipids, 164, 732-739 (2011).
5. Fang SH, Hou YC, Chang WC, Hsiu SL, Chao PD, Chiang BL. Morin sulfates/glucuronides exert anti-inflammatory activity on activated macrophages and decreased the incidence of septic shock. Life Sci., 74, 743-756 (2003).
6. Kang DG, Moon MK, Sohn EJ, Lee DH, Lee HS. Effects of morin on blood pressure and metabolic changes in fructose-induced hypertensive rats. Biol. Pharm. Bull., 27, 1779-1783 (2004).
7. Parihar VK, Prabhakar KR, Veerapur VP, Priyadarsini KI, Unnikrishnan MK, Rao CM. Anticlastogenic activity of morin against whole body gamma irradiation in Swiss albino mice. Eur. J. Pharmacol., 557, 58-65 (2007).
8. Sivaramakrishnan V, Shilpa PN, Praveen Kumar VR, Niranjali Devaraj S. Attenuation of N-nitrosodiethylamine-induced hepatocellular carcinogenesis by a novel flavonol-morin. Chem. Biol. Interact., 171, 79-88 (2008).
9. Machlin LJ, Bendich A. Free radical tissue damage: protective role of antioxidant nutrients. FASEB J., 1, 441-445 (1987).
10. Mukoda T, Sun B, Ishiguro A. Antioxidant activities of a buckwheat hull extract toward various oxidative stress in vitro and in vivo. Biol. Pharm. Bull., 24, 209-213 (2001).
11. Karbownik-Lewinska M, Gesing A, Zasada K, Jedrzejczyk M, Sobieszczanska-Jablonska A, Krawczyk J, Kokoszko-Bilska A, Zygmunt A, Lewinski A. Relationship between lipid peroxidation or carcinoembryonic antigen and risk factors for non-communicable diseases in women at midlife and beyond. Neuroendocrinol. Lett., 33, 536-545 (2012).
12. Liochev SI. Reactive oxygen species and the free radical theory of aging. Free Radic. Biol. Med., 60, 1-4 (2013).
13. Maes M, Mihaylova I, Kubera M, Uytterhoeven M, Vrydags N, Bosmans E. Increased plasma peroxides and serum oxidized low density lipoprotein antibodies in major depression: markers that further explain the higher incidence of neurodegeneration and coronary artery disease. J. Affect. Disord., 125, 287-294 (2010).
14. Wang MX, Jiao JH, Li ZY, Liu RR, Shi Q, Ma L. Lutein supplementation reduces plasma lipid peroxidation and C-reactive protein in healthy nonsmokers. Atherosclerosis, 227, 380-385 (2013).
15. Choi YA, Yoon YH, Choi K, Kwon M, Goo SH, Cha JS, Choi MK, Lee HS, Song IS. Enhanced oral bioavailability of morin administered in mixed micelle formulation with PluronicF127 and Tween80 in rats. Biol. Pharm. Bull., 38, 208-217 (2015).
16. Tian XJ, Yang XW, Yang X, Wang K. Studies of intestinal permeability of 36 flavonoids using Caco-2 cell monolayer model. Int. J. Pharm., 367, 58-64 (2009).
17. Zhang J, Peng Q, Shi S, Zhang Q, Sun X, Gong T, Zhang Z. Preparation, characterization, and in vivo evaluation of a self-nanoemulsifying drug delivery system (SNEDDS) loaded with morin-phospholipid complex. Int. J. Nanomedicine, 6, 3405-3414 (2011).
18. Pouton CW, Porter CJ. Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies. Adv. Drug Deliv. Rev., 60, 625-637 (2008).
19. Joshi MD, Müller RH. Lipid nanoparticles for parenteral delivery of actives. Eur. J. Pharm. Biopharm., 71, 161-172 (2009).
20. Ikeuchi-Takahashi Y, Sasatsu M, Onishi H. Evaluation of matrix type mucoadhesive tablets containing indomethacin for buccal application. Int. J. Pharm., 453, 454-461 (2013).
21. Ikeuchi-Takahashi Y, Watanabe N, Sasatsu M, Onishi H. Formulation and evaluation of matrix type mucoadhesive tablets aimed at treating oral aphtha. Drug Dev. Ind. Pharm., 39, 1254-1261 (2013).
22. Jose S, Anju SS, Cinu TA, Aleykutty NA, Thomas S, Souto EB. In vivo pharmacokinetics and biodistribution of resveratrol-loaded solid lipid nanoparticles for brain delivery. Int. J. Pharm., 474, 6-13 (2014).
23. Neves AR, Lúcio M, Martins S, Lima JL, Reis S. Novel resveratrol nanodelivery systems based on lipid nanoparticles to enhance its oral bioavailability. Int. J. Nanomedicine, 8, 177-187 (2013).
24. Dwivedi P, Khatik R, Khandelwal K, Taneja I, Raju KS, Wahajuddin, Paliwal SK, Dwivedi AK, Mishra PR. Pharmacokinetics study of arteether loaded solid lipid nanoparticles: an improved oral bioavailability in rats. Int. J. Pharm., 466, 321-327 (2014).
25. 2). J. Nanopart. Res., 17, 12 (2015).
26. Hou YC, Chao PD, Ho HJ, Wen CC, Hsiu SL. Profound difference in pharmacokinetics between morin and its isomer quercetin in rats. J. Pharm. Pharmacol., 55, 199-203 (2003).
27. Subedi RK, Kang KW, Choi HK. Preparation and characterization of solid lipid nanoparticles loaded with doxorubicin. Eur. J. Pharm. Sci., 37, 508-513 (2009).
28. Ulyanenkova T, Myronov M, Benediktovitch A, Mikhalychev A, Halpin J, Ulyanenkov A. Characterization of SiGe thin films using a laboratory X-ray instrument. J. Appl. Cryst., 46, 898-902 (2013).
29. Elgindy NA, Mehanna MM, Mohyeldin SM. Self-assembled nanoarchitecture liquid crystalline particles as a promising carrier for progesterone transdermal delivery. Int. J. Pharm., 501, 167-179 (2016).
30. El-Salamouni NS, Farid RM, El-Kamel AH, El-Gamal SS. Effect of sterilization on the physical stability of brimonidine-loaded solid lipid nanoparticles and nanostructured lipid carriers. Int. J. Pharm., 496, 976-983 (2015).
31. Abdulkarim M, Agulló N, Cattoz B, Griffiths P, Bernkop-Schnürch A, Borros SG, Gumbleton M. Nanoparticle diffusion within intestinal mucus: Three-dimensional response analysis dissecting the impact of particle surface charge, size and heterogeneity across polyelectrolyte, pegylated and viral particles. Eur. J. Pharm. Biopharm., 97 (Pt A), 230-238 (2015).
32. Bargoni A, Cavalli R, Caputo O, Fundarò A, Gasco MR, Zara GP. Solid lipid nanoparticles in lymph and plasma after duodenal administration to rats. Pharm. Res., 15, 745-750 (1998).
33. Zhang Z, Gao F, Bu H, Xiao J, Li Y. Solid lipid nanoparticles loading candesartan cilexetil enhance oral bioavailability: in vitro characteristics and absorption mechanism in rats. Nanomedicine, 8, 740-747 (2012).
34. Turk CT, Oz UC, Serim TM, Hascicek C. Formulation and optimization of nonionic surfactants emulsified nimesulide-loaded PLGA-based nanoparticles by design of experiments. AAPS PharmSciTech, 15, 161-176 (2014).
35. Saadati R, Dadashzadeh S. Marked effects of combined TPGS and PVA emulsifiers in the fabrication of etoposide-loaded PLGA-PEG nanoparticles: in vitro and in vivo evaluation. Int. J. Pharm., 464, 135-144 (2014).